| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Chiara Uboldi | Q61823008 |
| Sebastiano Di Bucchianico | Q57069471 | ||
| P2093 | author name string | Fabio Coppedè | |
| Lucia Migliore | |||
| P2860 | cites work | Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice | Q23917933 |
| Extrapulmonary transport of MWCNT following inhalation exposure | Q23920372 | ||
| Tight junctions of the blood-brain barrier: development, composition and regulation | Q24292730 | ||
| Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review | Q26864147 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 | ||
| Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10 | Q28384830 | ||
| The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution | Q28385395 | ||
| Size dependent aqueous dispersibility of carboxylated multiwall carbon nanotubes | Q28387754 | ||
| Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells | Q28388340 | ||
| A review of mammalian toxicity of ZnO nanoparticles | Q28389049 | ||
| In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms | Q28389093 | ||
| Silica nanoparticles induce oxidative stress and inflammation of human peripheral blood mononuclear cells | Q28391436 | ||
| Toward single-walled carbon nanotube-gadolinium complex as advanced MRI contrast agents: pharmacodynamics and global genomic response in small animals | Q28391991 | ||
| Astrocytes acquire resistance to iron-dependent oxidative stress upon proinflammatory activation | Q28393397 | ||
| Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration | Q28396482 | ||
| Transient modulation of acetylcholinesterase activity caused by exposure to dextran-coated iron oxide nanoparticles in brain of adult zebrafish | Q58310832 | ||
| Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide | Q60167269 | ||
| Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice | Q82207203 | ||
| Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes | Q82418857 | ||
| Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro | Q82781131 | ||
| Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles | Q83061683 | ||
| Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes | Q83466007 | ||
| Influence of liberated silver from silver nanoparticles on nitrification inhibition of Nitrosomonas europaea | Q84561058 | ||
| Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats | Q94698918 | ||
| Effects of copper nanoparticles on rat cerebral microvessel endothelial cells | Q95813869 | ||
| Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. | Q39412169 | ||
| The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis | Q39480109 | ||
| Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease | Q39528961 | ||
| Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways | Q39665104 | ||
| Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. | Q39676676 | ||
| Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells. | Q39704027 | ||
| Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. | Q39825368 | ||
| Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles | Q39833378 | ||
| Nanosized zinc oxide particles induce neural stem cell apoptosis | Q39855879 | ||
| Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells | Q39872423 | ||
| Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro | Q39913981 | ||
| Silica nanoparticles as hepatotoxicants | Q40001053 | ||
| Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. | Q40244635 | ||
| Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons | Q41503484 | ||
| Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus | Q42513005 | ||
| Inflammation and gene expression in the rat lung after instillation of silica nanoparticles: effect of size, dispersion medium and particle surface charge | Q42707157 | ||
| Titanium dioxide nanoparticles inhibit proliferation and induce morphological changes and apoptosis in glial cells. | Q42715510 | ||
| Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro | Q42716163 | ||
| Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging | Q42725476 | ||
| Vitamin E renders protection to PC12 cells against oxidative damage and apoptosis induced by single-walled carbon nanotubes | Q42725758 | ||
| Cytotoxicity of single-walled carbon nanotubes on PC12 cells | Q42795759 | ||
| Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells | Q42878166 | ||
| Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease | Q43200171 | ||
| Accumulation of iron oxide nanoparticles by cultured brain astrocytes. | Q43200824 | ||
| Inhibitory effects of multiwall carbon nanotubes with high iron impurity on viability and neuronal differentiation in cultured PC12 cells | Q44354982 | ||
| Effects of sub-acute exposure to TiO2, ZnO and Al2O3 nanoparticles on oxidative stress and histological changes in mouse liver and brain. | Q44471414 | ||
| Size- and age-dependent neurotoxicity of engineered metal nanoparticles in rats | Q44711325 | ||
| Role of copper in human neurological disorders | Q45290807 | ||
| Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats | Q45347595 | ||
| Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. | Q46017996 | ||
| The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. | Q46019748 | ||
| The role of the glutamatergic NMDA receptor in nanosilver-evoked neurotoxicity in primary cultures of cerebellar granule cells. | Q46132942 | ||
| Subchronic inhalation toxicity of silver nanoparticles. | Q46228935 | ||
| Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. | Q46358891 | ||
| Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease | Q46740678 | ||
| Toxicity and tissue distribution of magnetic nanoparticles in mice. | Q46764075 | ||
| Effects of nanoparticles on the adhesion and cell viability on astrocytes. | Q46965962 | ||
| Rutile TiO₂ particles exert size and surface coating dependent retention and lesions on the murine brain | Q47359864 | ||
| Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug p | Q47833362 | ||
| Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats | Q47981993 | ||
| Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology. | Q48169602 | ||
| Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease. | Q48262785 | ||
| Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats | Q48390882 | ||
| Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches | Q48402382 | ||
| Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. | Q48420682 | ||
| Cognitive impairment in rats induced by nano-CuO and its possible mechanisms | Q48432565 | ||
| Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. | Q48454007 | ||
| Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles | Q49014967 | ||
| Exacerbation of brain pathology after partial restraint in hypertensive rats following SiO₂ nanoparticles exposure at high ambient temperature | Q50231587 | ||
| Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies. | Q50668795 | ||
| Maternal exposure to titanium dioxide nanoparticles during pregnancy; impaired memory and decreased hippocampal cell proliferation in rat offspring. | Q50684245 | ||
| Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans. | Q51577756 | ||
| Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. | Q51865423 | ||
| Assessment of cellular responses after short- and long-term exposure to silver nanoparticles in human neuroblastoma (SH-SY5Y) and astrocytoma (D384) cells. | Q53059636 | ||
| Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles. | Q53114218 | ||
| Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. | Q53251443 | ||
| Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide. | Q53320369 | ||
| Synthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer's disease. | Q53349750 | ||
| Signal enhancement in antibody microarrays using quantum dots nanocrystals: application to potential Alzheimer's disease biomarker screening. | Q53438974 | ||
| Advances in motor neurone disease. | Q55545731 | ||
| Functionalized carbon nanotubes in the brain: cellular internalization and neuroinflammatory responses | Q28535210 | ||
| Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles | Q28572773 | ||
| Translocation of Inhaled Ultrafine Particles to the Brain | Q29547870 | ||
| Oxygen toxicity, oxygen radicals, transition metals and disease | Q29615096 | ||
| Dissolution of silver nanowires and nanospheres dictates their toxicity to Escherichia coli | Q30393162 | ||
| Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease | Q30537842 | ||
| SiO2 nanoparticles change colour preference and cause Parkinson's-like behaviour in zebrafish | Q30566261 | ||
| Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. | Q30666219 | ||
| Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation | Q30666255 | ||
| Engineered nanoparticles. How brain friendly is this new guest? | Q30819351 | ||
| Uptake and metabolism of iron oxide nanoparticles in brain cells. | Q30835947 | ||
| Body distribution of inhaled fluorescent magnetic nanoparticles in the mice | Q33320409 | ||
| Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles | Q33377703 | ||
| Effects of carbon nanotubes on primary neurons and glial cells | Q33451485 | ||
| Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells | Q33659863 | ||
| Silica-based nanoparticle uptake and cellular response by primary microglia | Q33837783 | ||
| The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development | Q33881257 | ||
| Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid β protein antibody-coated nanoparticles | Q33961318 | ||
| Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain | Q33982602 | ||
| Subchronic oral toxicity of silver nanoparticles | Q34083872 | ||
| Neurologic Wilson's disease | Q34098037 | ||
| DNA repair in premature aging disorders and neurodegeneration | Q34105057 | ||
| Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release | Q34480604 | ||
| Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences | Q34608061 | ||
| Molecular insights into Parkinson's disease | Q34988753 | ||
| Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate | Q35068083 | ||
| Effect of silica particle size on macrophage inflammatory responses | Q35134878 | ||
| Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors | Q35834280 | ||
| Cytotoxic effects of ZnO hierarchical architectures on RSC96 Schwann cells | Q36209638 | ||
| Medical application of functionalized magnetic nanoparticles | Q36289920 | ||
| Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease. | Q36571755 | ||
| Thinking laterally about neurodegenerative proteinopathies | Q36793466 | ||
| The pivotal role of astrocytes in the metabolism of iron in the brain. | Q36841623 | ||
| Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology | Q36889441 | ||
| Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases | Q37332243 | ||
| Delivery of peptide and protein drugs over the blood-brain barrier | Q37460463 | ||
| Nanotechnological applications for the treatment of neurodegenerative disorders | Q37504055 | ||
| Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease | Q37539279 | ||
| Photosensitive fluorescent dye contributes to phototoxicity and inflammatory responses of dye-doped silica NPs in cells and mice | Q37605956 | ||
| The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. | Q37626178 | ||
| Multimodal nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain | Q37674005 | ||
| Advances in the treatment of neurodegenerative disorders employing nanotechnology | Q37690357 | ||
| The transition metals copper and iron in neurodegenerative diseases | Q37732710 | ||
| Pathology, clinical features and treatments of congenital copper metabolic disorders – Focus on neurologic aspects | Q37812879 | ||
| Are commercially available nanoparticles safe when applied to the skin? | Q37844085 | ||
| Metal dyshomeostasis and oxidative stress in Alzheimer's disease | Q38043839 | ||
| Handling of iron oxide and silver nanoparticles by astrocytes | Q38066031 | ||
| Epigenetic effects of nano-sized materials | Q38067238 | ||
| Targeted drug delivery across the blood brain barrier in Alzheimer's disease | Q38102017 | ||
| Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems | Q38119315 | ||
| Nanocarriers for tracking and treating diseases | Q38120017 | ||
| Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches | Q38136249 | ||
| Inflammation in neurodegenerative diseases--an update | Q38170472 | ||
| Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles | Q38174718 | ||
| Nanocarrier-based approaches for treatment and detection of Alzheimer's disease | Q38204401 | ||
| Applications of biosynthesized metallic nanoparticles - a review. | Q38219894 | ||
| Effects of iron oxide nanoparticles: cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. | Q38248242 | ||
| Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells | Q38994641 | ||
| Titanium dioxide nanoparticles induce strong oxidative stress and mitochondrial damage in glial cells | Q38995292 | ||
| Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits. | Q39003875 | ||
| In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier | Q39034981 | ||
| Comparative study on effects of two different types of titanium dioxide nanoparticles on human neuronal cells. | Q39164086 | ||
| Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells | Q39211329 | ||
| Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles | Q39310480 | ||
| Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. | Q39359977 | ||
| Suppression of nanosilica particle-induced inflammation by surface modification of the particles | Q39379651 | ||
| Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles | Q39391621 | ||
| Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages | Q39406450 | ||
| P433 | issue | 2 | |
| P921 | main subject | nanomaterial | Q967847 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 149-170 | |
| P577 | publication date | 2015-01-28 | |
| P1433 | published in | Environmental and Molecular Mutagenesis | Q15724469 |
| P1476 | title | Nanomaterials and neurodegeneration | |
| P478 | volume | 56 |
| Q38779910 | A panel of in vitro tests to evaluate genotoxic and morphological neoplastic transformation potential on Balb/3T3 cells by pristine and remediated titania and zirconia nanoparticles. |
| Q89976081 | Commitment of Autologous Human Multipotent Stem Cells on Biomimetic Poly-L-lactic Acid-Based Scaffolds Is Strongly Influenced by Structure and Concentration of Carbon Nanomaterial |
| Q38738079 | Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model. |
| Q57470537 | Effects of silica nanoparticles on endolysosome function in primary cultured neurons |
| Q92636091 | Evaluation of cytotoxicity and genotoxicity induced by oleic acid-coated iron oxide nanoparticles in human astrocytes |
| Q60907603 | INSIdE NANO: a systems biology framework to contextualize the mechanism-of-action of engineered nanomaterials |
| Q97546264 | Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia |
| Q61087357 | Lessons learned from research on air pollution and other particles in the toxicology of nanomaterials and vice versa |
| Q89910191 | Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances |
| Q57341436 | Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping. |
| Q41679021 | Neurotoxic effect of active ingredients in sunscreen products, a contemporary review |
| Q36242578 | Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction |
Search more.